EU Import Regulations for Adult Incontinence Products: Complete Guide

Importing adult incontinence products into the European Union requires navigating a complex regulatory landscape that has become significantly more stringent since the Medical Device Regulation (MDR 2017/745) came into full effect in May 2021. For distributors and wholesalers looking to source adult diapers, underpads, and related hygiene products, understanding these regulations is not just about compliance—it's about protecting your business from costly delays, rejections at customs, and potential legal liabilities.

This comprehensive guide breaks down the essential regulatory requirements, customs procedures, and documentation you need to successfully import incontinence products into EU markets.

Medical Device Classification and CE Marking Requirements

The first critical point to understand is that adult incontinence products fall under the EU Medical Devices Regulation (MDR 2017/745), not general consumer goods legislation. Most incontinence products are classified as Class I medical devices, which means they must carry CE marking before they can be legally placed on the EU market.

CE marking signifies that a product meets all applicable EU safety, health, and environmental protection requirements. For incontinence products, this involves:

• Technical documentation: Comprehensive files demonstrating product design, manufacturing processes, risk analysis, and clinical evaluation
• Declaration of Conformity: A formal document signed by the manufacturer stating compliance with all relevant directives
• Quality management system: ISO 13485 certification or equivalent quality assurance procedures
• Post-market surveillance: Systems for tracking product performance and reporting adverse events

When sourcing from suppliers like KERA's European manufacturing network, which operates certified facilities in Belgium, France, and Greece, the CE marking process is already completed. This eliminates one of the most significant barriers for distributors entering the market, as establishing compliance from scratch can take 6-12 months and cost upwards of €50,000 for manufacturers outside the EU.

Customs Classification and Import Duties

Accurate customs classification is essential for calculating import duties and ensuring smooth clearance. Adult incontinence products typically fall under the following HS (Harmonized System) codes:

• 9619 0090: Sanitary towels and tampons, napkins and napkin liners for babies and similar sanitary articles, of any material (most common for adult diapers)
• 5601 21 90: Wadding of textile materials and articles thereof (for certain underpad types)
• 6307 90 98: Other made-up textile articles (for specific reusable products)

Import duty rates for incontinence products from outside the EU typically range from 0% to 6.3%, depending on the specific classification and country of origin. Products manufactured within the EU—such as those from KERA's Belgian, French, and Greek facilities—move freely within the single market without customs duties, a significant cost advantage for EU-based distributors.

Value-Added Tax (VAT) applies to all imports, with rates varying by member state. Most EU countries apply reduced VAT rates (0-10%) to medical devices including incontinence products, recognizing their essential healthcare function. For example, the UK applies 0% VAT, Ireland 0%, France 5.5%, and Spain 4%.

Essential Import Documentation

Importing incontinence products into the EU requires a comprehensive documentation package. Missing or incomplete paperwork is the most common cause of customs delays, which can result in storage fees, product deterioration, and lost sales opportunities.

Required Documents

1. Commercial Invoice: Detailed description of goods, HS codes, unit prices, total value, Incoterms, and payment terms
2. Packing List: Complete itemization of shipment contents, quantities, weights, and dimensions
3. Bill of Lading or Air Waybill: Transport document serving as receipt and contract
4. Certificate of Origin: Document certifying the country where goods were manufactured (may qualify for preferential duty rates under trade agreements)
5. CE Declaration of Conformity: Manufacturer's signed statement of regulatory compliance
6. Technical Documentation Summary: Overview of product specifications, materials, and intended use
7. Test Reports: Laboratory results demonstrating product safety and performance (absorption capacity, skin compatibility, etc.)
8. Import License: Required in some member states for medical devices (check national requirements)

Working with established European manufacturers simplifies this process considerably. When distributors partner with suppliers like KERA, all CE documentation and technical files are provided as part of the standard order package, eliminating the need to coordinate with third-party testing laboratories or notified bodies.

Country-Specific Import Considerations

While the EU operates as a single market for goods, individual member states maintain certain national requirements that affect incontinence product imports.

Germany

Germany requires registration with the German Institute of Medical Documentation and Information (DIMDI) for medical devices before market placement. The process typically takes 2-4 weeks and costs approximately €400-600 per product category.

France

French authorities require medical device importers to register with ANSM (Agence Nationale de Sécurité du Médicament). Products must have labeling and instructions for use in French language. France also maintains strict requirements for sustainable packaging, with extended producer responsibility (EPR) fees for hygiene products.

Spain

Spain requires registration with AEMPS (Agencia Española de Medicamentos y Productos Sanitarios). All product labeling and patient information must be in Spanish. Import authorization can take 30-60 days for first-time importers.

United Kingdom (Post-Brexit)

Following Brexit, the UK now requires UKCA marking (UK Conformity Assessed) instead of CE marking for goods sold in Great Britain. However, CE marking continues to be accepted until June 2027. Products must have a UK Responsible Person registered with the MHRA (Medicines and Healthcare products Regulatory Agency). For Northern Ireland, CE marking remains valid under the Protocol on Ireland/Northern Ireland.

Product Testing and Performance Standards

Beyond regulatory compliance, importers should verify that products meet recognized performance standards to ensure quality and minimize returns or complaints.

Key Standards for Incontinence Products

• ISO 11948-1: Urine-absorbing aids—Test method for characterizing polymer-based absorbent materials
• EN 15649: Textiles—Determination of fluid absorption capacity
• ISO 10993 series: Biological evaluation of medical devices (skin contact, cytotoxicity, sensitization)
• EN 13726: Test methods for primary wound dressings (applicable to certain high-performance products)

Premium manufacturers conduct third-party testing through accredited laboratories to verify absorption capacity, leakage prevention, skin compatibility, and material safety. KERA products, for instance, undergo comprehensive testing with absorption ranges verified from 2,500ml for day-use products up to 4,300ml for overnight protection—data that's critical for healthcare facilities and institutional buyers making purchasing decisions.

Labeling and Language Requirements

Product labeling must comply with MDR requirements and include specific mandatory information in the language(s) of the target market:

• Manufacturer name and address
• Product identifier and batch/lot number
• CE marking with notified body number (if applicable)
• Intended use and performance claims
• Warnings and precautions
• Storage conditions and shelf life
• Instructions for use
• Material composition (especially important for latex allergies)

Multilingual labeling is common for products distributed across multiple EU markets. Manufacturers like KERA typically provide labeling in English, French, Spanish, German, and Italian as standard, streamlining the process for distributors serving pan-European markets.

Incoterms and Shipping Considerations

The choice of Incoterms significantly affects your import responsibilities, costs, and risk exposure.

Common Incoterms for Incontinence Product Imports

• EXW (Ex Works): Buyer handles all transport, insurance, and customs clearance. Offers maximum control but requires established logistics capabilities. This is KERA's standard term, with pickup available from warehouses in Belgium, France, or Greece.
• FOB (Free on Board): Seller delivers to port of shipment; buyer handles sea freight and import clearance. Common for non-EU imports.
• CIF (Cost, Insurance, Freight): Seller handles transport and insurance to destination port; buyer handles import clearance and inland transport.
• DDP (Delivered Duty Paid): Seller handles everything including import duties. Highest cost but lowest complexity for buyer.

For EU-to-EU transactions, EXW or FCA (Free Carrier) terms are most efficient since no customs procedures are required. Distributors can arrange direct pickup from manufacturing facilities or consolidate shipments at regional warehouses to optimize freight costs.

Container Loading and Minimum Order Quantities

Incontinence products have relatively low density but high volume, making container optimization crucial for cost-effective importing.

A standard 40-foot high-cube (HC) container can typically accommodate:

• 35,000-45,000 pieces of adult pull-up pants (depending on size)
• 25,000-35,000 pieces of tape-style adult diapers
• 50,000-65,000 pieces of bed underpads (60x90cm or 90x180cm)
• 80,000-100,000 pieces of light incontinence pads

Most European manufacturers set minimum order quantities at one full container load per quarter, which ensures economies of scale while allowing distributors to maintain reasonable inventory turnover. This MOQ structure—used by suppliers like KERA—balances manufacturer production efficiency with distributor cash flow requirements.

Quality Assurance and Inspection Protocols

Implementing quality control procedures at the import stage protects against receiving defective goods and establishes accountability with suppliers.

Recommended Inspection Points

1. Pre-shipment inspection: Third-party verification before goods leave the manufacturing facility (photographs, sample testing, quantity verification)
2. Container inspection: Visual examination upon arrival for damage, moisture, or tampering
3. Sample testing: Random sampling from each batch for absorption testing, seal integrity, and material defects
4. Documentation audit: Verification that all certificates, test reports, and declarations match the shipped products

Establishing quality metrics in supply agreements—such as maximum acceptable defect rates (typically 0.5-1% for premium products) and clear protocols for handling non-conforming goods—prevents disputes and ensures consistent product quality.

Post-Import Obligations and Vigilance

Your regulatory responsibilities don't end when products clear customs. As a distributor or importer, you have ongoing obligations under the MDR:

• Product traceability: Maintaining records linking batch numbers to customers for potential recall situations
• Adverse event reporting: Notifying authorities of serious incidents or safety concerns within required timeframes (typically 15 days)
• Storage conditions: Maintaining appropriate temperature and humidity levels to preserve product integrity
• Expiry date management: FIFO (first-in, first-out) inventory rotation to prevent selling expired products

Many distributors underestimate these post-import requirements, but they're essential for legal compliance and protecting your business reputation. Working with manufacturers who provide comprehensive support documentation and clear batch tracking systems makes compliance far more manageable.

Brexit Implications for UK Importers

UK importers face additional complexity following Brexit. Key changes include:

• Customs declarations now required for goods entering from the EU
• UKCA marking required by June 2027 (CE marking accepted until then)
• UK Responsible Person registration mandatory with MHRA
• Potential for divergence in UK standards from EU regulations over time

Many European manufacturers have appointed UK Responsible Persons to simplify the process for UK distributors. This service is typically included at no additional cost, maintaining the ease of doing business that existed before Brexit.

Cost Analysis: EU vs. Non-EU Manufacturing

When comparing import costs, EU-sourced products often provide better total landed cost despite potentially higher unit prices:

For many distributors, especially those starting in the market or serving multiple EU countries, EU-manufactured products offer superior risk-adjusted value despite unit price differences of 10-25%.

Practical Steps for New Importers

If you're planning to import incontinence products into the EU market, follow this step-by-step approach:

1. Identify target markets: Determine which EU member states you'll serve and research their specific national requirements
2. Obtain EORI number: Register for an Economic Operators Registration and Identification number (required for customs operations)
3. Verify supplier compliance: Request and review CE certificates, technical documentation, and test reports before placing orders
4. Establish customs broker relationship: Partner with experienced brokers familiar with medical device imports (if importing from outside EU)
5. Set up quality control protocols: Define inspection procedures and acceptable quality levels
6. Create compliance documentation system: Implement procedures for maintaining required records (typically 10-year retention for medical devices)
7. Calculate total landed cost: Include all duties, freight, insurance, storage, and compliance costs in your pricing model
8. Plan inventory management: Account for lead times, shelf life (typically 3-5 years for incontinence products), and storage requirements

Why Regulatory Compliance Matters for Your Business

Beyond legal obligations, proper import compliance delivers tangible business benefits:

• Market access: Ability to sell to healthcare facilities, pharmacies, and institutional buyers who require verified compliance
• Competitive advantage: Many small importers cut corners on compliance; proper procedures differentiate your business
• Risk mitigation: Protection against product recalls, legal liabilities, and reputational damage
• Customer confidence: Professional distributors with proper documentation win larger contracts
• Scalability: Established compliance procedures make expansion into additional markets far easier

Conclusion: Partnering for Compliance Success

Successfully importing adult incontinence products into the EU requires navigating complex regulatory requirements, managing detailed documentation, and maintaining ongoing compliance obligations. While the learning curve can seem daunting, partnering with established European manufacturers who handle CE marking, provide comprehensive documentation, and offer multi-warehouse distribution significantly simplifies the process.

For distributors seeking to enter or expand in the European incontinence products market, working with experienced partners who understand both regulatory requirements and commercial realities is essential. Whether you're sourcing products for healthcare institutions, pharmacy chains, or online retail channels, ensuring full compliance from day one protects your investment and builds the foundation for sustainable growth.

Ready to explore EU-compliant incontinence product solutions with comprehensive documentation and multi-country distribution support? Learn more about KERA's distributor program or request sample products and compliance documentation to evaluate quality and regulatory completeness for your market.